Publications related to central nervous system , Sheba, 2006

Publications related to central nervous system , Sheba, 2004-2005

1.Achiron A, Polliack M, Rao SM, Barak Y, Lavie M, Appelboim N, Harel Y.

Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves.

J Neurol Neurosurg Psychiatry. 2005 May;76(5):744-9. (Full Text)

2.Achiron A, Gurevich M, Magalashvili D, Kishner I, Dolev M, Mandel M. 

Understanding autoimmune mechanisms in multiple sclerosis using gene expression microarrays: treatment effect and cytokine-related pathways.
Clin Dev Immunol. 2004 Sep-Dec;11(3-4):299-305.

3. Achiron A. 

 Predicting the course of relapsing-remitting MS using longitudinal disability curves. 

 J Neurol. 2004 Sep;251 Suppl 5:v65-v68. (Full Text)

4. Achiron A.
Chemokine polymorphisms: candidates for MS susceptibility and disease course.
Int MS J. 2004 Dec;11(3):71-7.

5.  Achiron A, Kishner I, Sarova-Pinhas I, Raz H, Faibel M, Stern Y, Lavie M,
Gurevich M, Dolev M, Magalashvili D, Barak Y.  

Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trial.

Arch Neurol. 2004 Oct;61(10):1515-20. (Full Text)

6. Achiron A, Edelstein S, Ziev-Ner Y, Givon U, Rotstein Z, Barak Y.

Bone strength in multiple sclerosis: cortical midtibial speed-of-sound assessment.

Mult Scler. 2004 Oct;10(5):488-93.

7. Achiron A, Lavie G, Kishner I, Stern Y, Sarova-Pinhas I, Ben-Aharon T, Barak Y, Raz H, Lavie M, Barliya T, Faibel M, Cohen IR, Mandel M.  

T cell vaccination in multiple sclerosis relapsing-remitting nonresponders patients.

Clin Immunol. 2004 Nov;113(2):155-60. (Full Text)

8. Achiron A, Kishner I, Dolev M, Stern Y, Dulitzky M, Schiff E, Achiron R. 

Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis.
 J Neurol. 2004 Sep;251(9):1133-7. (Full Text)

9. Achiron A, Gurevich M, Friedman N, Kaminski N, Mandel M.
 Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activity.

Ann Neurol. 2004 Mar;55(3):410-7. (Full Text)

10. Achiron A, Mandel M.
  T-cell vaccination in multiple sclerosis.
 Autoimmun Rev. 2004 Jan;3(1):25-32. (Full Text)

11. Achiron R, Kivilevitch Z, Lipitz S, Gamzu R, Almog B, Zalel Y.

 Development of the human fetal pons: in utero ultrasonographic study.

Ultrasound Obstet Gynecol. 2004 Oct;24(5):506-10.

12.  Achiron R, Zalel Y, Lipitz S, Hegesh J, Mazkereth R, Kuint J, Jacobson J,Yagel S.
 Fetal lung dysplasia: clinical outcome based on a new classification system.
Ultrasound Obstet Gynecol. 2004 Aug;24(2):127-33.

13. Achiron A, Miron S, Shoenfeld Y.
Does the flap of a butterfly's wings in Brazil set off a tornado in Texas?--The
JC Virus Story in multiple sclerosis.
Isr Med Assoc J. 2005 May;7(5):283-5. Review. No abstract available. (Full Text)  

14. Achiron A, Polliack M, Rao SM, Barak Y, Lavie M, Appelboim N, Harel Y.
Cognitive patterns and progression in multiple sclerosis: construction and
validation of percentile curves.
J Neurol Neurosurg Psychiatry. 2005 May;76(5):744-9. .(Full Text)

15.  Adler Y, Fisman EZ, Shemesh J, Schwammenthal E, Tanne D, Batavraham IR, Motro M, Tenenbaum A.
 Spiral computed tomography evidence of close correlation between coronary and thoracic aorta calcifications.
Atherosclerosis. 2004 Sep;176(1):133-8. (Full Text)

16.  Adunsky A, Chesnin V, Ravona R, Harats D, Davidson M.
 Plasma lipid levels in Alzheimer's disease patients treated by Donepezil hydrochloride: a cross-sectional study.
 Arch Gerontol Geriatr. 2004 Jan-Feb;38(1):61-8. (Full Text)

17. Aminoff BZ, Purits E, Noy S, Adunsky A.
Measuring the suffering of end-stage dementia: reliability and validity of the Mini-Suffering State Examination.
Arch Gerontol Geriatr. 2004 Mar-Apr;38(2):123-30. (Full Text)

18. Amital D, Fostick L, Sasson Y, Kindler S, Amital H, Zohar J.
Anxiogenic effects of Sumatriptan in panic disorder: A double-blind, placebo-controlled study.
Eur Neuropsychopharmacol. 2005 May;15(3):279-82. (Full Text)

19. Attia M, Harnof S, Knoller N, Shacked I, Zibly Z, Bedrin L, Regev-Yochay G.
 Cervical Pott's disease presenting as a retropharyngeal abscess.
Isr Med Assoc J. 2004 Jul;6(7):438-9. No abstract available.  (Full Text)

20. Attia M, Menhel J, Alezra D, Pffefer R, Spiegelmann R.
 Radiosurgery--LINAC or gamma knife: 20 years of controversy revisited.
Isr Med Assoc J. 2005 Sep;7(9):583-8. Review. No abstract available. (Full text)

21. Barak Y, Achiron A.
 Cognitive fatigue in multiple sclerosis: Findings from a two-wave screening project.
J Neurol Sci. 2006 Apr 17; [Epub ahead of print]

22. Barshack I, Polak-Charcon S, Behar V, Vainshtein A, Zik O, Ofek E, Hadani M,
Kopolovic J, Nass D.
Wet SEM: a novel method for rapid diagnosis of brain tumors.
Ultrastruct Pathol. 2004 Jul-Aug;28(4):255-60.

23. Benveniste, H. Fowler, J. Roony, W. Biegon, A.  Gatley, S.J. and Volkow, N.
Maternal and Fetal [11C]cocaine uptake and kinetics in pregnant non-human primates measured in vivo by combined  PET and MRI.
J. Nuc. Med. in press (2005). (Full Text)

24. Ben-Zeev B, Kivity S, Pshitizki Y, Watemberg N, Brand N, Kramer U.
Congenital hydrocephalus and continuous spike wave in slow-wave sleep--a common association? J Child Neurol. 2004 Feb;19(2):129-34. (Full Text)

25.  Biegon A.
 Cannabinoids as neuroprotective agents in traumatic brain injury.
Curr Pharm Des. 2004;10(18):2177-83. Review.

26.  Biegon A, Fry PA, Paden CM, Alexandrovich A, Tsenter J, Shohami E.
 Dynamic changes in N-methyl-D-aspartate receptors after closed head injury in mice: Implications for treatment of neurological and cognitive deficits.
Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):5117-22. Epub 2004 Mar 24.  (Full Text)

27. Borodkin K, Ayalon L, Kanety H, Dagan Y.
Dysregulation of circadian rhythms following prolactin-secreting pituitary
microadenoma.
Chronobiol Int. 2005;22(1):145-56. (Full Text)

28.  Chapman J.
 The interface of multiple sclerosis and antiphospholipid antibodies.
Thromb Res. 2004;114(5-6):477-81. (Full Text)

29.  Dagan Y, Borodkin K.
The ineffectiveness of magnotherapy in a patient with obstructive sleep apnea syndrome and cardiovascular comorbidity.
Sleep Breath. 2004 Dec;8(4):209-12. (Full Text)

30. Dannon PN, Gon-Usishkin M, Gelbert A, Lowengrub K, Grunhaus L.
Cognitive behavioral group therapy in panic disorder patients: the efficacy of CBGT versus drug treatment.
Ann Clin Psychiatry. 2004 Jan-Mar;16(1):41-6.

31.  Dannon PN, Lowengrub K, Sasson M, Shalgi B, Tuson L, Saphir Y, Kotler M.
 Comorbid psychiatric diagnoses in kleptomania and pathological gambling: a preliminary comparison study.
Eur Psychiatry. 2004 Aug;19(5):299-302. (Full Text)

32.  Dannon PN, Iancu I, Cohen A, Lowengrub K, Grunhaus L, Kotler M.
 Three year naturalistic outcome study of panic disorder patients treated with paroxetine.
BMC Psychiatry. 2004 Jun 11;4(1):16.(Full Text)

33.  Dannon PN, Lowengrub KM, Iancu I, Kotler M.
 Kleptomania: comorbid psychiatric diagnosis in patients and their families.
Psychopathology. 2004 Mar-Apr;37(2):76-80. (Full Text)

34.  Dannon PN, Lowengrub K, Amiaz R, Grunhaus L, Kotler M.
 Comorbid cannabis use and panic disorder: short term and long term follow-up study.
Hum Psychopharmacol. 2004 Mar;19(2):97-101. (Full Text)

35. Davidson M, Weiser M.
Prodromal schizophrenia: the dilemma of prediction and early intervention.

 CNS Spectr. 2004 Aug;9(8):578. (Full Text)

36.  Denys D, Zohar J, Westenberg HG.
 The Role of Dopamine in Obsessive-Compulsive Disorder: Preclinical and Clinical Evidence.
J Clin Psychiatry. 2004 Dec;65(SUPPLEMENT 14):11-17. (Full Text)

37.  Ding YS, Fowler JS, Logan J, Wang GJ, Telang F, Garza V, Biegon A, Pareto D,
Rooney W, Shea C, Alexoff D, Volkow ND, Vocci F.
 6-[18F]Fluoro-A-85380, a new PET tracer for the nicotinic acetylcholine receptor: studies in the human brain and in vivo demonstration of specific binding in white matter.
Synapse. 2004 Sep 1;53(3):184-9. No abstract available. (Full Text)

38. Doljansky JT, Kannety H, Dagan Y.

Working under daylight intensity lamp: an occupational risk for developing

circadian rhythm sleep disorder?

Chronobiol Int. 2005;22(3):597-605.

39. Frohman EM, Stuve O, Havrdova E, Corboy J, Achiron A, Zivadinov R, Sorensen PS, Phillips JT, Weinshenker B, Hawker K, Hartung HP, Steinman L, Zamvil S, Cree BA, Hauser S, Weiner H, Racke MK, Filippi M.
Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations.
Arch Neurol. 2005 Oct;62(10):1519-30. Review. (Full Text)

40. Goldberg-Zimring D, Achiron A, Warfield SK, Guttmann CR, Azhari H.
 Application of spherical harmonics derived space rotation invariant indices to the analysis of multiple sclerosis lesions' geometry by MRI.
Magn Reson Imaging. 2004 Jul;22(6):815-25. (Full Text)

41. Goldberg-Zimring D, Shalmon B, Zou KH, Azhari H, Nass D, Achiron A.

Assessment of Multiple Sclerosis Lesions with Spherical Harmonics: Comparison of MR Imaging and Pathologic Findings.

Radiology. 2005 Apr 15.

42.  Gross-Isseroff R, Cohen R, Sasson Y, Voet H, Zohar J.
 Serotonergic dissection of obsessive compulsive symptoms: a challenge study with m-chlorophenylpiperazine and sumatriptan.
Neuropsychobiology. 2004;50(3):200-5.(Full Text)

43. Grossman R, Feldman Z.
Bone growth causing ventriculoperitoneal shunt malfunction in a patient with osteopetrosis. Case report. 

 J Neurosurg Spine. 2004 May;100(5):530-1.(Full Text)

44. Grossman R, Feldman Z.

Subacute formation of syrinx post-untethering of spinal cord.

Pediatr Neurosurg. 2004 Sep-Oct;40(5):234-7. (Full text)

45. Grossman R, Sadetzki S, Spiegelmann R, Ram Z.

Haemorrhagic complications and the incidence of asymptomatic bleeding associated with stereotactic brain biopsies.

Acta Neurochir (Wien). 2005 Apr 15. (Full Text)

46. Henkin Y, Sadeh M, Kivity S, Shabtai E, Kishon-Rabin L, Gadoth N.
Cognitive function in idiopathic generalized epilepsy of childhood.
Dev Med Child Neurol. 2005 Feb;47(2):126-32. (full text)

47.  Hollander E, Zohar J.
 Introduction: beyond refractory obsessions and anxiety States: toward remission.
J Clin Psychiatry. 2004;65 Suppl 14:3-5. (Full Text)

48. Kaminski N, Achiron A.
Can Blood Gene Expression Predict Which Patients with Multiple Sclerosis Will Respond to Interferon?
PLoS Med. 2005 Feb;2(2):e33. Epub 2005 Feb 22. (Full text)

49. Koton S, Schwammenthal Y, Merzeliak O, Philips T, Tsabari R, Bruk B, Orion
D, Rotstein Z, Chapman J, Tanne D.
 Effectiveness of establishing a dedicated acute stroke unit in routine clinical practice in Israel.
Isr Med Assoc J. 2005 Nov;7(11):688-93. (Full text) 

50. Knoller N, Auerbach G, Fulga V, Zelig G, Attias J, Bakimer R, Marder JB,
Yoles E, Belkin M, Schwartz M, Hadani M.
Clinical experience using incubated autologous macrophages as a treatment for
complete spinal cord injury: phase I study results.
J Neurosurg Spine. 2005 Sep;3(3):173-81.

51. Krause I, Lev S, Fraser A, Blank M, Lorber M, Stojanovich L, Rovensky J,
Chapman J, Shoenfeld Y.
 Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome.
Ann Rheum Dis. 2005 Oct;64(10):1490-3. Epub 2005 Mar 18.  (Full text) 

52. Lidar Z, Mardor Y, Jonas T, Pfeffer R, Faibel M, Nass D, Hadani M, Ram Z.
Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study.
J Neurosurg. 2004 Mar;100(3):472-9. (Full Text)

53. Lubina A, Olchovsky D, Berezin M, Ram Z, Hadani M, Shimon I.
 Management of pituitary apoplexy: clinical experience with 40 patients.
Acta Neurochir (Wien). 2004 Dec 2. (Full Text) 

54. Mandel M, Gurevich M, Lavie G, Cohen IR, Achiron A.
 Unique gene expression patterns in human T-cell lines generated from multiple sclerosis patients by stimulation with a synthetic MOG peptide.
Clin Dev Immunol. 2005 Sep;12(3):203-9.

55. Mandel M, Gurevich M, Pauzner R, Kaminski N, Achiron A. 

Autoimmunity gene expression portrait: specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosus.

Clin Exp Immunol. 2004 Oct;138(1):164-70. (Full Text)

56.  Mardor Y, Roth Y, Ochershvilli A, Spiegelmann R, Tichler T, Daniels D, Maier
SE, Nissim O, Ram Z, Baram J, Orenstein A, Pfeffer R.
Pretreatment prediction of brain tumors' response to radiation therapy using
high b-value diffusion-weighted MRI.
Neoplasia. 2004 Mar-Apr;6(2):136-42. (Full Text)

57. Nissim O, Bakon M, Ben Zeev B, Goshen E, Knoller N, Hadani M, Feldman Z.

Moyamoya disease--diagnosis and treatment: indirect cerebral revascularization

at the Sheba Medical Center.

Isr Med Assoc J. 2005 Oct;7(10):661-6. (Full Text)

58.  Pareto D, Alvarado M, Hanrahan SM, Biegon A.
 In vivo occupancy of female rat brain estrogen receptors by 17beta-estradiol and tamoxifen.
Neuroimage. 2004 Nov;23(3):1161-7. (Full Text)

59. Peles E, Lidar Z, Simon AJ, Grossman R, Nass D, Ram Z.
 Angiogenic factors in the cerebrospinal fluid of patients with astrocytic brain tumors. Neurosurgery. 2004 Sep;55(3):562-7; discussion 567-8. (Full Text)

60. Polat U, Ma-Naim T, Belkin M, Sagi D.
Improving vision in adult amblyopia by perceptual learning.
Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6692-7. (Full Text)  

61.  Roth Y, Tichler T, Kostenich G, Ruiz-Cabello J, Maier SE, Cohen JS, Orenstein A, Mardor Y.
 High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice.
Radiology. 2004 Sep;232(3):685-92. Epub 2004 Jun 23. (Full Text)

62. Rubinfeld H, Hadani M, Taylor JE, Dong JZ, Comstock J, Shen Y, DeOliveira D, Datta R, Culler MD, Shimon I.
Novel ghrelin analogs with improved affinity for the GH secretagogue receptor stimulate GH and prolactin release from human pituitary cells.
Eur J Endocrinol. 2004 Dec;151(6):787-95. (Full Text)

63. Rubinek T, Rubinfeld H, Hadani M, Barkai G, Shimon I.

 Nitric oxide stimulates growth hormone secretion from human fetal pituitaries and cultured pituitary adenomas.

Endocrine. 2005 Nov;28(2):209-16.

64. Sasson Y, Dekel S, Nacasch N, Chopra M, Zinger Y, Amital D, Zohar J.
Posttraumatic obsessive-compulsive disorder: a case series.
Psychiatry Res. 2005 Jun 15;135(2):145-52. (Full Text)

65. Sharabi Y, Dagan Y, Grossman E.
Sleep apnea as a risk factor for hypertension.
Curr Opin Nephrol Hypertens. 2004 May;13(3):359-64. (Full Text)

66. Shoenfeld Y, Lev S, Blatt I, Blank M, Font J, von Landenberg P, Lev N, Zaech J, Cervera R, Piette JC, Bertolaccini ML, Hughes GR, Youinou P, Meroni PL, Pengo V, Alves JD, Tincani A, Szegedi G, Lakos G, Sturfelt G, Jonsen A, Koike T, Sanmarco M, Ruffatti A, Ulcova-Gallova Z, Praprotnik S, Rozman B, Lorber M, Chapman J, van-Breda-Vriezman PJ, Damoiseaux J.
Features associated with epilepsy in the antiphospholipid syndrome.
 J Rheumatol. 2004 Jul;31(7):1344-8.

67.  Schlegel DJ, Tanne D, Demchuk AM, Levine SR, Kasner SE; Multicenter rt-PA
Stroke Survey Group. 

Prediction of hospital disposition after thrombolysis for acute ischemic stroke
using the National Institutes of Health Stroke Scale.
Arch Neurol. 2004 Jul;61(7):1061-4. (Full Text)

68.  Schwammenthal Y, Tanne D.
 Homocysteine, B-vitamin supplementation, and stroke prevention: from observational to interventional trials.
Lancet Neurol. 2004Aug;3(8):493-5. (Full Text)

69. Schwammenthal Y, Tanne D.
 Salvaging brain: new concepts in the management of acute stroke.
Isr Med Assoc J. 2004 Oct;6(10):628-9. (Full Text).

70.  Schwammenthal Y, Drescher MJ, Merzeliak O, Tsabari R, Bruk B, Feibel M, Hoffman C, Bakon M, Rotstein Z, Chapman J, Tanne D.
 Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
Isr Med Assoc J. 2004 Feb;6(2):70-4. (Full Text)

71. Stein D, Maayan R, Ram A, Loewenthal R, Achiron A, Modan-Moses D, Feigin M,

Weizman A, Valevski A.

Circulatory neurosteroid levels in underweight female adolescent anorexia

nervosa inpatients and following weight restoration.

Eur Neuropsychopharmacol. 2005 Jul 12 . (Full Text)

72. Stuart WH, Cohan S, Richert JR, Achiron A.
Selecting a disease-modifying agent as platform therapy in the long-termmanagement of multiple sclerosis.
Neurology. 2004 Dec 14;63(11 Suppl 5):S19-27. Review. (Full Text)

73. Tanne D, Goldbourt U, Medalie JH.
Perceived Family Difficulties and Prediction of 23-Year Stroke Mortality among
Middle-Aged Men.
Cerebrovasc Dis. 2004 Aug 24;18(4):277-282 [Epub ahead of print] (Full Text)

74.  Tanne D, Koren-Morag N, Goldbourt U.
Fasting plasma glucose and risk of incident ischemic stroke or transient
ischemic attacks: a prospective cohort study.
Stroke. 2004 Oct;35(10):2351-5. Epub 2004 Aug 12. (Full Text)

75. Tanne D, Medalie JH, Goldbourt U.

Body fat distribution and long-term risk of stroke mortality.

Stroke. 2005 May;36(5):1021-5.  (Full Text)

76. Weiser M, Davidson M, Noy S.
Comments on risk for schizophrenia.
Schizophr Res. 2005 Nov 1;79(1):15-21. Epub 2005 Jun 17. (Full Text)

77. Weiser M, Knobler H, Lubin G, Nahon D, Kravitz E, Caspi A, Noy S, Knobler HY, Davidson M.
 Body Mass Index and Future Schizophrenia in Israeli Male Adolescents.
J Clin Psychiatry. 2004 Nov;65(11):1546-1549. (Full Text)

78. Weiser M, Noy S.
Interpreting the association between cannabis use and increased risk for schizophrenia.
Dialogues Clin Neurosci. 2005;7(1):81-5. Review.

79. Weiser M, Reichenberg A, Rabinowitz J, Knobler HY, Lubin G, Yazvitzky R, Nahon D, Gur RC, Davidson M.

Cognitive performance of male adolescents is lower than controls across psychiatric disorders: a  population-based study.
Acta Psychiatr Scand. 2004 Dec;110(6):471-5. (Full Text)

80. Weiser M, Reichenberg A, Grotto I, Yasvitzky R, Rabinowitz J, Lubin G, Nahon
D, Knobler HY, Davidson M.
 Higher rates of cigarette smoking in male adolescents before the onset of schizophrenia: a historical-prospective cohort study.
Am J Psychiatry. 2004 Jul;161(7):1219-23. (Full Text)

81. Weiser M, Kanyas K, Malaspina D, Harvey PD, Glick I, Goetz D, Karni O, Yakir A, Turetsky N, Fennig S, Nahon D, Lerer B, Davidson M.
Sensitivity of ICD-10 diagnosis of psychotic disorders in the Israeli National Hospitalization Registry compared with RDC diagnoses based on SADS-L.

Compr Psychiatry. 2005 Jan-Feb;46(1):38-42.  (Full text)

82. Ziporen L, Polak-Charcon S, Korczyn DA, Goldberg I, Afek A, Kopolovic J,
Chapman J, Shoenfeld Y.
 Neurological dysfunction associated with antiphospholipid syndrome:
histopathological brain findings of thrombotic changes in a mouse model.
Clin Dev Immunol. 2004 Mar;11(1):67-75.

83. Zohar J, Kennedy JL, Hollander E, Koran LM.
 Serotonin-1D Hypothesis of Obsessive-Compulsive Disorder: An Update.
J Clin Psychiatry. 2004 Dec;65(SUPPLEMENT 14):18-21.

84. Zohar J.
 Are all atypical antipsychotics equal for the treatment of cognition and affect in schizophrenia?
CNS Spectr. 2004 Oct;9(10 Suppl 11):5.

85. Zwecker M, Zeilig G, Ohry A.
 Professor Heinrich Sebastian Frenkel: a forgotten founder of rehabilitation medicine.
Spinal Cord. 2004 Jan;42(1):55-6.